Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission.

Source:http://linkedlifedata.com/resource/pubmed/id/15170169

Download in:

View as

General Info

PMID
15170169